These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 8088189
1. Inhibitory effects of high molecular weight substances from CAPD dialysate on mouse bone marrow progenitor cells and lymphocyte transformation. Yang CL, Du XH, Wu H. Chin Med J (Engl); 1994 Apr; 107(4):248-53. PubMed ID: 8088189 [Abstract] [Full Text] [Related]
2. Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients. Carozzi S, Ramello A, Nasini MG, Schelotto C, Caviglia PM, Cantaluppi A, Salit M, Lamperi S. Adv Perit Dial; 1990 Apr; 6():312-5. PubMed ID: 1982836 [Abstract] [Full Text] [Related]
3. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ. Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340 [Abstract] [Full Text] [Related]
4. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M. Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658 [Abstract] [Full Text] [Related]
5. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G. Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026 [Abstract] [Full Text] [Related]
6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V, Ferguson KF, Heller G, Kernan NA. Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [Abstract] [Full Text] [Related]
7. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates. Liang DC, Shih LY, Kuo MC, Chai IJ, Su TH, Chen SH, Liu HC, Shimosaka A. Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233 [Abstract] [Full Text] [Related]
8. Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells. Jaar B, Baillou C, Viron B, Michel C, Mignon F, Najman A. Nephrol Dial Transplant; 1993 Sep; 8(7):614-20. PubMed ID: 8396745 [Abstract] [Full Text] [Related]
9. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents. Takatsuki F, Miyasaka Y, Kikuchi T, Suzuki M, Hamuro J. Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970 [Abstract] [Full Text] [Related]
10. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A, Arai K. Oncologist; 1996 Feb; 1(5):337-339. PubMed ID: 10388012 [Abstract] [Full Text] [Related]
11. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM. Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568 [Abstract] [Full Text] [Related]
12. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O'Neill WJ, Fisher JW. J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997 [Abstract] [Full Text] [Related]
13. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Malgor LA, Valsecia M, Vergés E, De Markowsky EE. Acta Physiol Pharmacol Ther Latinoam; 1998 Dec; 48(2):99-105. PubMed ID: 9695882 [Abstract] [Full Text] [Related]
14. Circulating burst-forming unit-erythroid (BFU-E) colonies as an early marker to measure the recombinant human erythropoietin response in peritoneal dialysis patients. Castro MA, Fernandez de Castro M, Selgas R, Fernandez-Reyes MJ, Bajo MA, Jimenez C, Del Peso G, Dapena F, de Alvaro F. Adv Perit Dial; 1996 Dec; 12():66-70. PubMed ID: 8865876 [Abstract] [Full Text] [Related]
15. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure. Biljanović-Paunović L, Djukanović L, Lezaić V, Stojanović N, Marisavljević D, Pavlović-Kentera V. Eur J Med Res; 1998 Dec 16; 3(12):564-70. PubMed ID: 9889177 [Abstract] [Full Text] [Related]
16. Effect of human cytomegalovirus on proliferation of hematopoietic progenitor cells of cord blood. Liu WJ, Jin RM, Fu XD, Liu B, Guo QL, Deng ZH. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr 16; 8(2):85-9. PubMed ID: 16613695 [Abstract] [Full Text] [Related]
17. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure. Glaser M. Med Sci Monit; 2006 Mar 16; 12(3):CR113-7. PubMed ID: 16501421 [Abstract] [Full Text] [Related]
18. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis. Carozzi S, Nasini MG, Santoni O, Tirotta A, Sanna A. ASAIO J; 1997 Mar 16; 43(5):M535-8. PubMed ID: 9360100 [Abstract] [Full Text] [Related]
19. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis. Wideröe TE, Sanengen T, Halvorsen S. Kidney Int Suppl; 1983 Dec 16; 16():S208-17. PubMed ID: 6588251 [Abstract] [Full Text] [Related]
20. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro. Wang CQ, Udupa KB, Lipschitz DA. J Cell Physiol; 1996 Feb 16; 166(2):305-10. PubMed ID: 8591990 [Abstract] [Full Text] [Related] Page: [Next] [New Search]